| F2 |
F2: Prothrombin precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
323.000 |
Evidence |
O
|
| PLG |
PLG: Plasminogen precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
320.000 |
Evidence |
O
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
314.000 |
Evidence |
O
|
| PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
314.000 |
Evidence |
O
|
| SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
LSM2 |
LSM2, C6orf28, G7b: U6 snRNA-associated Sm-like protein LSm2 |
312.000 |
Evidence |
O
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
299.000 |
Evidence |
O
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
299.000 |
Evidence |
O
|
| PSMD10 |
PSMD10: 26S proteasome non-ATPase regulatory subunit 10 |
PSMC3 |
PSMC3, TBP1: 26S protease regulatory subunit 6A |
293.000 |
Evidence |
O
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
293.000 |
Evidence |
O
|
| PSMA2 |
PSMA2, PSC3: Proteasome subunit alpha type-2 |
PSMB6 |
PSMB6, LMPY: Proteasome subunit beta type-6 precursor |
280.000 |
Evidence |
O
|
| PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
280.000 |
Evidence |
O
|
| PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
PSMD13 |
PSMD13: 26S proteasome non-ATPase regulatory subunit 13 |
280.000 |
Evidence |
O
|
| LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
LSM4 |
LSM4: U6 snRNA-associated Sm-like protein LSm4 |
279.000 |
Evidence |
O
|
| RFX1 |
RFX1: MHC class II regulatory factor RFX1 |
RFX2 |
RFX2: DNA-binding protein RFX2 |
276.000 |
Evidence |
O
|
| PSMC3 |
PSMC3, TBP1: 26S protease regulatory subunit 6A |
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
272.000 |
Evidence |
O
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
268.000 |
Evidence |
O
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
268.000 |
Evidence |
O
|
| PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
PSMD6 |
PSMD6, KIAA0107, PFAAP4: 26S proteasome non-ATPase regulatory subunit 6 |
262.000 |
Evidence |
O
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
SUPT16H |
SUPT16H, FACT140, FACTP140: FACT complex subunit SPT16 |
256.000 |
Evidence |
O
|
| POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
252.000 |
Evidence |
O
|
| PDK1 |
PDK1: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial precu |
PDK2 |
PDK2: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial precu |
249.000 |
Evidence |
O
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
237.000 |
Evidence |
O
|
| BOP1 |
BOP1, KIAA0124: Ribosome biogenesis protein BOP1 |
DDX24 |
DDX24: ATP-dependent RNA helicase DDX24 |
232.000 |
Evidence |
O
|
| XPOT |
XPOT: Exportin-T |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
232.000 |
Evidence |
O
|
| F8 |
F8, F8C: Coagulation factor VIII precursor |
F9 |
F9: Coagulation factor IX precursor |
230.000 |
Evidence |
O
|
-